Status:
COMPLETED
DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart Failure
Lead Sponsor:
Mitsui Memorial Hospital
Collaborating Sponsors:
Mitsukoshi Health and Welfare Foundation
Conditions:
Heart Failure
Diabetes Mellitus
Eligibility:
All Genders
20+ years
Phase:
PHASE4
Brief Summary
We thought to investigate the influence of DPP-4 inhibitor on the serum BNP level of diabetic patients with congestive heart failure. This study consists of two protocols. In the first protocol, diabe...
Eligibility Criteria
Inclusion
- Outpatient arm
- Type 2 diabetes patient with congestive heart failure under treatment with DPP-4 inhibitor (sitagliptin, vildagliptin, alogliptin, linagliptin, teneligliptin, anagliptin or saxagliptin) .
- High serum BNP (100-2000pg/ml).
- Patients who have given informed consent to participation in the study.
Exclusion
- HbA1c over 9.0%.
- Patients who changed medication within 1 months before inclusion.
- Judged as ineligible by clinical investigators.
- Hospitalization arm
- Inclusion Criteria:
- Type 2 diabetes patient who were hospitalized for congestive heart failure.
- Patients who have given informed consent to participation in the study.
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT02312427
Start Date
January 1 2015
End Date
March 1 2016
Last Update
March 22 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mitsui Memorial Hospital
Taito-ku, Tokyo, Japan